| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 69481 |
cas:124529-64-2，tert-butyl 6-(2,5-dioxo-2H-pyrrol-1(5H)-yl)hexylcarbamate |
78 |
h |
2024-12-25 |
| 69482 |
淫羊藿素脂质体(聚乙二醇化)，Icaritin Liposome (PEGylated) |
125 |
axc |
2024-12-25 |
| 69483 |
cas:146474-00-2，1-(2-Aminoethyl)-1H-pyrrole-2,5-dione TFA salt |
83 |
h |
2024-12-25 |
| 69484 |
CBZ-NH-PEG3-CH2COOH cas:462100-05-6 |
84 |
zyl |
2024-12-25 |
| 69485 |
Ald-Ph-amido-PEG2，1061569-06-9，ADC试剂 |
63 |
hyy |
2024-12-25 |
| 69486 |
mPEG24-Hydrazide，甲氧基二十四聚乙二醇酰肼 |
139 |
wyh |
2024-12-25 |
| 69487 |
双氢青蒿素脂质体，Dihydroartemisinin Liposome |
71 |
axc |
2024-12-25 |
| 69488 |
cas:7423-55-4，3-Maleimidopropionic acid，抗体偶联药物 |
141 |
h |
2024-12-25 |
| 69489 |
mPEG11-Hydrazide，甲氧基十一聚乙二醇-酰肼 |
68 |
wyh |
2024-12-25 |
| 69490 |
青蒿素脂质体，Artemisinin Liposome |
123 |
axc |
2024-12-25 |
| 69491 |
cas:2054345-67-2，N3-tris(ethylenoxy)-L-alanine TFA Salt |
76 |
h |
2024-12-25 |
| 69492 |
cas:1155811-37-2 H2N-PEG1-CH2COOtBu的结构式 |
132 |
zyl |
2024-12-25 |
| 69493 |
Ald-Ph-amido-PEG4-C2-NHS ester，1353011-74-1，抗体- 药物偶联物 |
80 |
hyy |
2024-12-25 |
| 69494 |
cas:1398044-54-6，2-t-Butoxycarbonylamino-1,3-bis(carboxyethoxy)propane |
87 |
h |
2024-12-25 |
| 69495 |
2-（2-羟基-5-氨基苯基）苯并咪唑（NH2-HBI） |
84 |
WYQ |
2024-12-25 |
| 69496 |
枸橼酸托法替尼脂质体，Tofacitinib Citrate Liposome |
115 |
axc |
2024-12-25 |
| 69497 |
cas:2028284-70-8，Sulfo DBCO-amine，抗体偶联药物 |
66 |
h |
2024-12-25 |
| 69498 |
四苯基卟啉四磺酸钠（TPPSNa） |
103 |
WYQ |
2024-12-25 |
| 69499 |
DBCO-CONH-PEG12-CH2CH2COONHS的结构式 |
70 |
zyl |
2024-12-25 |
| 69500 |
cas:1353016-70-2，DBCO-acid，抗体偶联药物 |
97 |
h |
2024-12-25 |
| 69501 |
cas:98604-88-7，bis(2,5-dioxopyrrolidin-1-yl) 4,4'-disulfanediyldibutanoate |
142 |
h |
2024-12-25 |
| 69502 |
四-[3-甲氧基-4-(N-咔唑)正丁氧苯基]卟啉（4C4-TPP） |
101 |
WYQ |
2024-12-25 |
| 69503 |
Ald-Ph-amido-PEG3-C1-Boc，1007215-94-2，ADC试剂 |
68 |
hyy |
2024-12-25 |
| 69504 |
mPEG3-Hydrazide，甲氧基三聚乙二醇-酰肼 |
131 |
wyh |
2024-12-25 |
| 69505 |
DBCO-CONH-PEG12-CH2CH2COOH的介绍 |
69 |
zyl |
2024-12-25 |
| 69506 |
cas:1324007-10-4，2,3,4,5,6-pentafluorophenyl 1-[(4-formylphenyl)formamido]-3,6,9,12-tetraoxapentadecan-15-oate |
78 |
h |
2024-12-25 |
| 69507 |
唑来膦酸脂质体，Zoledronic Acid Liposome |
124 |
axc |
2024-12-25 |
| 69508 |
不对称酰胺基卟啉5-(4-棕榈酸酰亚胺基)苯基-10,15,20-三苯基卟啉（PITPPH2） |
102 |
WYQ |
2024-12-25 |
| 69509 |
盐酸拓扑替康脂质体(聚乙二醇化)，Topotecan Hydrochloride Liposome (PEGylated) |
118 |
axc |
2024-12-25 |
| 69510 |
DBCO-CONH-PEG4-CH2CH2COONHS的结构式 |
86 |
zyl |
2024-12-25 |
| 69511 |
perfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
78 |
h |
2024-12-25 |
| 69512 |
他莫昔芬脂质体，Tamoxifen Liposome |
90 |
axc |
2024-12-25 |
| 69513 |
2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate |
95 |
h |
2024-12-25 |
| 69514 |
Methyltetrazine-CH2NHCO-PEG9-Biotin |
80 |
zyl |
2024-12-25 |
| 69515 |
藤黄酸脂质体，Gambogic Acid Liposome |
75 |
axc |
2024-12-25 |
| 69516 |
cas:1006592-59-1，2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate |
74 |
h |
2024-12-25 |
| 69517 |
Ald-Ph-amido-PEG3-C2-Pfp ester，2101206-21-5，抗体- 药物偶联物 |
66 |
hyy |
2024-12-25 |
| 69518 |
mPEG6-N3，甲氧基六聚乙二醇叠氮 |
67 |
wyh |
2024-12-25 |
| 69519 |
阿达帕林弹性脂质体，Adapalene Elastic Liposome |
122 |
axc |
2024-12-25 |
| 69520 |
5-对-(4-溴丁氧基)苯基-10,15,20-三苯基卟啉(BrBPTPP) |
67 |
WYQ |
2024-12-25 |
| 69521 |
cas:1347750-84-8，MAL-Tetra-EG-OPFP，抗体偶联药物 |
62 |
h |
2024-12-25 |
| 69522 |
Methyltetrazine-CH2NHCO-PEG4-Biotin cas:1962919-31-8 生物素-四聚乙二醇-甲基四嗪 |
65 |
zyl |
2024-12-25 |
| 69523 |
甲氧基五聚乙二醇-巯基，mPEG5-SH |
68 |
wyh |
2024-12-25 |
| 69524 |
Adapalene Flexible Liposome 阿达帕林柔性脂质体 |
91 |
axc |
2024-12-25 |
| 69525 |
1-((1r,4r)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
53 |
h |
2024-12-25 |
齐岳微信公众号
官方微信
库存查询